Latest Oncology Stories
GAITHERSBURG, Md., Feb. 10, 2015 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. and Accelovance Inc.
BCC Research (http://www.bccresearch.com) reveals in its new report on breast cancer diagnostic and drug technologies that many side effects,
The report’s publication follows the issuance of two power morcellator warnings from the FDA regarding the potential for morcellation to spread undetected uterine cancers. New
Agreement ensures continuing broad patient access to Quest's BRCAvantage(TM) services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb.
Large-scale study shows potential for non-invasive test to be made available to millions of women worldwide who are unscreened for the detection of cervical cancer SAN DIEGO, Feb.
Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.
First state oncology society to offer such a tumor board BOISE, Idaho, Feb.
LUGANO, Switzerland and SINGAPORE, February 9, 2015 /PRNewswire/ -- The exclusive agreement builds on our existing partnerships in the area of cancer supportive care across
The new report suggests that thousands of people who worked in the hairstyling industry may be at risk for deadly malignant mesothelioma from the asbestos in older hairdryers. Raleigh,
- In medieval musical notation, a sign or neume denoting a shake or trill.